Previous close | 16.95 |
Open | 16.84 |
Bid | 14.34 x 800 |
Ask | 0.00 x 800 |
Day's range | 16.47 - 17.03 |
52-week range | 13.05 - 23.25 |
Volume | |
Avg. volume | 1,723,606 |
Market cap | 1.946B |
Beta (5Y monthly) | 0.98 |
PE ratio (TTM) | 15.30 |
EPS (TTM) | 1.10 |
Earnings date | 03 Aug 2022 - 08 Aug 2022 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | 07 Oct 2008 |
1y target est | 23.44 |
CHICAGO, May 11, 2022--Researchers from Veradigm®, a leading provider of healthcare data and technology solutions, will present health economics and outcomes research (HEOR) data on Covid-19, diabetes, NASH (Non-Alcoholic Steatohepatitis), and cardiovascular disease at the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) in Washington, D.C. from May 15-18, 2022.
Allscripts' (MDRX) robust Q1 results demonstrate strength in both segments.
AllScripts (MDRX) delivered earnings and revenue surprises of -35% and 61.72%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?